IRIS
GRASSADONIA, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.971
EU - Europa 2.711
AS - Asia 1.253
OC - Oceania 17
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
Totale 6.971
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.962
IE - Irlanda 544
IT - Italia 518
SG - Singapore 450
CN - Cina 436
SE - Svezia 361
UA - Ucraina 342
FR - Francia 316
GB - Regno Unito 242
TR - Turchia 224
DE - Germania 142
IN - India 79
RU - Federazione Russa 72
FI - Finlandia 61
VN - Vietnam 40
BE - Belgio 29
CZ - Repubblica Ceca 29
PL - Polonia 21
AU - Australia 13
CA - Canada 8
LT - Lituania 8
TW - Taiwan 8
HK - Hong Kong 6
EG - Egitto 5
ES - Italia 5
EU - Europa 5
BR - Brasile 4
CH - Svizzera 4
NL - Olanda 4
NZ - Nuova Zelanda 4
JP - Giappone 3
RO - Romania 3
AT - Austria 2
IL - Israele 2
LU - Lussemburgo 2
MA - Marocco 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DK - Danimarca 1
DZ - Algeria 1
IR - Iran 1
KR - Corea 1
LV - Lettonia 1
MX - Messico 1
PK - Pakistan 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 6.971
Salva come PNG Salva come JPEG
Città #
Chandler 663
Dublin 533
Jacksonville 441
Singapore 394
Princeton 205
Southend 170
Izmir 133
Nanjing 130
Ashburn 128
Beijing 102
Santa Clara 94
Chieti 91
Wilmington 85
Altamura 84
Ann Arbor 84
Dearborn 84
Boardman 67
Cambridge 63
Los Angeles 45
Dong Ket 40
New York 39
Nanchang 38
Pescara 33
Brussels 29
Woodbridge 28
Washington 27
Rome 24
Brno 23
Hebei 22
Kunming 20
Shenyang 20
Norwalk 19
Tianjin 19
Jiaxing 18
Kraków 18
Falls Church 14
Munich 13
Changsha 12
Grevenbroich 12
Milan 12
Houston 11
Hangzhou 9
Helsinki 8
Changchun 7
Melbourne 7
Tappahannock 7
Augusta 6
Corridonia 6
Guangzhou 6
Hefei 6
Lanciano 6
Menlo Park 6
Oklahoma City 6
Seattle 6
Taipei 6
Auburn Hills 5
Bristol 5
Cairo 5
Chicago 5
Edinburgh 5
Jinan 5
Lanzhou 5
London 5
Moscow 5
Romola 5
Carini 4
Denver 4
Garden City 4
Lappeenranta 4
Loma Linda 4
L’Aquila 4
Montorio al Vomano 4
Napoli 4
Nuremberg 4
Penne 4
Spoltore 4
Ameno 3
Amsterdam 3
Aprilia 3
Aquila 3
Collecorvino 3
Madrid 3
Montesilvano Marina 3
Mumbai 3
Olomouc 3
Perego 3
Perth 3
Pune 3
San Mateo 3
San Vito Chietino 3
Savigliano 3
Scarborough 3
Simi Valley 3
Sulmona 3
Zurich 3
Andover 2
Antrodoco 2
Bari 2
Bellante 2
Bollate 2
Totale 4.340
Salva come PNG Salva come JPEG
Nome #
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 115
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. 111
90K (Mac-2 BP) and galectins in tumor progression and metastasis. 100
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. 100
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 97
Glicomimetici quali potenziali nuovi farmaci per la prevenzione delle metastasi. 96
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 96
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 96
Occupational allergy: is there a role for nanoparticles? 96
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 96
The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. 93
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 92
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 90
Gli analoghi sintetici delle glicoamine come potenziali nuovi farmaci nella prevenzione delle metastasi 89
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein. 89
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer 88
Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells 87
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 86
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors 86
Principali effetti collaterali delle terapie mediche 86
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 86
A novel serum test using interferon for early detection of tumor reccurrence in cancer patients after radical surgery. 85
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 85
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag 84
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 84
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 84
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice. 83
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression 83
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 82
Exosomes as pleiotropic players in pancreatic cancer 82
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients. 81
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 80
Analisi dello stato mutazionale di K-RAS: un nuovo strumento per la selezione dei pazienti candidati a terapia con anticorpi anti-EGFR 80
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey 80
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions. 79
Tumor-derived microvesicles: The metastasomes. 79
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 78
New Targets for Therapy in Pancreatic Cancer 78
The Role of the Environment and Type of Exercise on Acute Adrenal Modulation and Perceived Distress of Breast Cancer Survivors Practising Light-Intensity Physical Exercise 78
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies 77
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial. 77
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage 77
TGF-β-1 increases 90K tumor associated antigen gene expression by increasing upstream regulatory factor binding to the minimal promoter. 76
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 76
La stimolazione dinamica con IFN-α per la diagnosi precoce di ripresa di malattia in pazienti NED 75
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 74
Regolazione, funzione ed espressione genica dell’antigene tumore-associato 90K/AC-2 BP 73
Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer 73
BIOLOGICAL INDICATORS OF PROGNOSIS IN HUMAN CANCER: AN EMERGING ROLE FOR LECTIN GALACTOSIDE-BINDING SOLUBLE 3-BINDING PROTEIN (LGALS3BP) 73
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: A systematic review 72
Circadian timing of chemotherapeutic agents:a phase II study of 5-fluoro-2-deoxyuridine in gastrointestinal cancer and renal cell carcinoma 71
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? 70
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer 69
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly 68
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 68
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 68
Elevated serum level of a 90,000 daltons tumor-associated antigen in cancer and infection by Human Immunodeficiency Virus ( HIV) 67
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 67
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial 66
Possible role of thymidylate synthase level in hunan colorectal carcinoma: a new prognostic factor? 64
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. 64
Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function 64
Impact of Body Mass Index (BMI) on outcome of metastatic breast cancer (MBC) patients (pts) treated with Eribulin in a real-world population: a multicenter retrospective study 64
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 64
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 63
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 63
Infusione cronomodulata di farmaci in oncologia 61
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 61
Oral etoposide and platinum derivates in the treatment of metastatic Merkel cell carcinoma: report of three cases 60
Prognostic value of a novel interferon-inducible 90K tumor antigen 59
Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study 57
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study. 57
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 56
Alectinib induced regression of renal and hepatic cysts caused by crizotinib 56
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer 55
FPSE-HPLC-DAD metod for the quantification of anticancer drugs in human whole blood, plasma and urine 55
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting 55
Effect of taxanes following anthracyclines on pathologic complete response (pCR) in patients with triple-negative breast cancer (TNBC) receiving primary systemic therapy (PST). 54
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 54
Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression 53
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study 53
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 53
Current challenges in HER2-positive breast cancer 52
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 52
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 52
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 51
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 51
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 50
Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review 47
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 47
Relationships between daily physical activity combinations and psychophysical health status of Italian breast cancer survivors 47
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 46
Eribulin in triple negative metastatic breast cancer: Critic interpretation of current evidence and projection for future scenarios 43
Pretreatment neutrophil-lymphocyte ratio (NLR) predicted overall survival (OS) for metastatic melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) patients who received monotherapy with immune checkpoint inhibitor as ipilimumab, nivolumab and pembrolizumab 41
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 41
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 40
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 39
Prognostic value of gender and primary tumor location in metastatic colon cancer 39
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer 37
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma 37
Totale 7.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020783 0 0 0 36 106 85 123 88 95 114 129 7
2020/2021612 98 8 100 9 37 115 18 19 42 62 41 63
2021/2022560 19 15 5 118 35 32 15 47 33 15 62 164
2022/20231.857 144 237 160 193 192 334 99 156 212 16 70 44
2023/20241.034 87 31 66 44 64 331 174 30 41 33 25 108
2024/2025876 137 392 326 21 0 0 0 0 0 0 0 0
Totale 7.461